Eliem Therapeutics Inc (ELYM)
7.59
-0.07
(-0.91%)
USD |
NASDAQ |
May 31, 16:00
7.68
+0.09
(+1.19%)
After-Hours: 20:00
Eliem Therapeutics Cash and Short Term Investments (Annual): 106.80M for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.80M |
| December 31, 2022 | 123.57M |
| December 31, 2021 | 136.48M |
| Date | Value |
|---|---|
| December 31, 2020 | 20.49M |
| December 31, 2019 | 21.22M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
20.49M
Minimum
2020
136.48M
Maximum
2021
81.71M
Average
106.80M
Median
2023
Cash and Short Term Investments (Annual) Benchmarks
| Alpine Immune Sciences Inc (DELISTED) | 327.41M |
| Candel Therapeutics Inc | 35.41M |
| Cyclacel Pharmaceuticals Inc | 3.378M |
| Lipocine Inc | 22.04M |
| GlycoMimetics Inc | 41.79M |